Abdulla A. Damluji Questions Evidence for Beta-Blockers After MI Without Heart Failure
Abdulla A. Damluji, an interventional cardiologist at Cleveland Clinic, posted on X:
”Beta-Blockers after Myocardial Infarction in Patients without Heart Failure: NEJM, ESC Congress
Is evidence still in favor of beta blockers post AMI?”
Read the article here.
Title: Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
Authors: John Munkhaugen, Anna Meta D. Kristensen, Sigrun Halvorsen, Therese Holmager, Michael Hecht Olsen, Arnhild Bakken, Thomas S.G. Sehested, Vidar Ruddox, Michael Mæng, Kjell Vikenes, Svend E. Jensen, Terje Steigen, Jess Lambrechtsen, Jarle Jortveit, Ann Bovin, Henrik Schirmer, Morten Krogh Christiansen, Rune Wiseth, Dennis Mikkelsen, Alf Inge Larsen, Camilla Lyngby Kjærgaard, Kristoffer Andresen, Ida Gustafsson, Vegard Tuseth, Mogens Lytken Larsen, Peter Stefan Deeg, Karsten Veien, Ellen Bøhmer, Hans Erik Bøtker, Anja Otrebska Brattrud, Jens Brønnum-Schou, Alf-Åge Reistad Pettersen, Lia Evi Bang, Erik Øie, Thomas Engstrøm, Eva Bostad Borg, Kjeld Kristensen, Ståle Haugset Nymo, Gunnar Gislason, Nils Tore Vethe, Jawdat Abdul Majid Abdulla, Toril Dammen, Mette Rauhe Mouridsen, Bjørn Bendz, Mette Lykke Norgaard Bertelsen, Jens Dahlgaard Hove, Louise Schierbeck, Martin Snoer, Cedric Davidsen, Gro Egholm, Kristian Korsgaard Thomsen, Ghassan Jadou, Monica Poenaru, Nikolaj Thure Krarup, Morten Böttcher, Peter Bisgaard Stæhr, Ann-Dorthe Zwisler, Thor Edvardsen, Christian Torp-Pedersen, Jan Erik Otterstad, Theis Lange, Morten W. Fagerland, Dan Atar, and Eva Prescott

Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis
